Get 20% lifetime commission for referring investors to digrin.com
here.
Keros Therapeutics, Inc. ( KROS) - Key Metrics
KROS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.45 | -$1.03 | -$1.04 |
| 2026Q1 | $0.02 | -$1.21 | -$0.18 | -$0.18 |
| 2025Q4 | $0.01 | -$0.86 | -$1 | -$1.01 |
| 2025Q3 | $0.35 | -$0.18 | $0.08 | $0.08 |
| 2025Q2 | $0.45 | -$0.76 | -$0.73 | -$0.75 |
KROS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.84 |
| 2026Q1 | 0% | -2.28 |
| 2025Q4 | 0% | -5.92 |
| 2025Q3 | 0% | -21.97 |
| 2025Q2 | 0% | -4.39 |
KROS
Price: $10.66
52 week price:
Earnings Per Share: -3.22 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 412500
Market Capitalization: 225.2 million